Fasting in Ramadan is not recommended for people with type 1 diabetes. The main risk associated with fasting is dysglycemia (hypoglycemia, hyperglycemia, diabetic ketosis) and dehydration. Nevertheless, whether or not to practice Ramadan remains a personal choice and many people living with diabetes choose to perform this fast with or without their physician's approval. The purpose of this prospective observational study is to evaluate the safety and efficacy of an closed-loop hybrid insulin system on glycemic parameters and the level of hypoglycemia in patients with type 1 diabetes who wished to fast during Ramadan.
Primary objective: to evaluate the efficacy of an closed-loop hybrid insulin system on continuous glucose monitoring (CGM) glycemic parameters during the Ramadan fasting period Primary endpoint : to compare the time spent in the 3.9-10.0 mmol/l glucose target (TIR) from 30 days prior to the Ramadan fasting period to 30 days during the fasting period
Study Type
OBSERVATIONAL
Enrollment
23
observational non-interventional study
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France
Glucose time
time spent in the 3.9-10.0 mmol/l glucose target (TIR)) in the Ramadan period
Time frame: Day 30
Glucose time
The time spent in the 3.9-10.0 mmol/l glucose target (TIR)) in 30 days prior the Ramadan period
Time frame: Day 60
Glucose time
time spent below target 3.9 mmol/l
Time frame: Day 30
Glucose time
time spent below target 2.97 mmol/l, between 2.97 and 3.79 mmol/l, between 9.05 mmol/l and 12.5mmol/l and \> 12.5 mmol/l
Time frame: Day 60
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.